Luo Q - Search Results

1

PEGylated nanostructured lipid carriers (PEG-NLC) as a novel drug delivery system for biochanin A.

Wang L, Luo Q, Lin T, Li R, Zhu T, Zhou K, Ji Z, Song J, Jia B, Zhang C, Chen W, Zhu G. Wang L, et al. Among authors: luo q. Drug Dev Ind Pharm. 2015;41(7):1204-12. doi: 10.3109/03639045.2014.938082. Epub 2014 Jul 10. Drug Dev Ind Pharm. 2015. PMID: 25010850

2

PEGylated non-ionic surfactant vesicles as drug delivery systems for Gambogenic acid.

Lin T, Fang Q, Peng D, Huang X, Zhu T, Luo Q, Zhou K, Chen W. Lin T, et al. Among authors: luo q. Drug Deliv. 2013 Sep-Oct;20(7):277-84. doi: 10.3109/10717544.2013.836618. Drug Deliv. 2013. PMID: 24044645 Free article.

3

Long circulation nanostructured lipid carriers for gambogenic acid: formulation design, characterization, and pharmacokinetic.

Lin T, Huang X, Wang Y, Zhu T, Luo Q, Wang X, Zhou K, Cheng H, Peng D, Chen W. Lin T, et al. Among authors: luo q. Xenobiotica. 2017 Sep;47(9):793-799. doi: 10.1080/00498254.2016.1229084. Epub 2016 Dec 5. Xenobiotica. 2017. PMID: 27618478 Free article.

4

A novel glyceryl monoolein-bearing cubosomes for gambogenic acid: Preparation, cytotoxicity and intracellular uptake.

Luo Q, Lin T, Zhang CY, Zhu T, Wang L, Ji Z, Jia B, Ge T, Peng D, Chen W. Luo Q, et al. Int J Pharm. 2015 Sep 30;493(1-2):30-9. doi: 10.1016/j.ijpharm.2015.07.036. Epub 2015 Jul 21. Int J Pharm. 2015. PMID: 26209071

5

Improved dissolution rate and bioavailability of fenofibrate pellets prepared by wet-milled-drug layering.

Wang P, Luo Q, Miao Y, Ying L, He H, Cai C, Tang X. Wang P, et al. Among authors: luo q. Drug Dev Ind Pharm. 2012 Nov;38(11):1344-53. doi: 10.3109/03639045.2011.650647. Epub 2012 Jan 28. Drug Dev Ind Pharm. 2012. PMID: 22283480

6

Increased dissolution and oral absorption of itraconazole/Soluplus extrudate compared with itraconazole nanosuspension.

Zhang K, Yu H, Luo Q, Yang S, Lin X, Zhang Y, Tian B, Tang X. Zhang K, et al. Among authors: luo q. Eur J Pharm Biopharm. 2013 Nov;85(3 Pt B):1285-92. doi: 10.1016/j.ejpb.2013.03.002. Epub 2013 Apr 3. Eur J Pharm Biopharm. 2013. PMID: 23562534

7

Orbital mesenchymal chondrosarcoma: a case report.

Luo Q, Wu S. Luo Q, et al. J Int Med Res. 2025 Jan;53(1):3000605241311443. doi: 10.1177/03000605241311443. J Int Med Res. 2025. PMID: 39852313

8

CKAP2L Plays a Pivotal Role in Colorectal Cancer Progression via the Dual Regulation of Cell Cycle and Epithelial-Mesenchymal Transition.

Luo Q, Zhu B, Wang C, Wang Y. Luo Q, et al. Discov Med. 2025 Jan;37(192):182-192. doi: 10.24976/Discov.Med.202537192.15. Discov Med. 2025. PMID: 39851233

9

Oridonin Suppresses the Malignant Progression of Lung Cancer by Targeting S100A11.

Luo Y, Li J, Chen Y, Huang Y, Luo Q, Luo Q, Huang Q, Huang G, Jin M. Luo Y, et al. Among authors: luo q. Curr Med Chem. 2025 Jan 23. doi: 10.2174/0109298673352893241228015939. Online ahead of print. Curr Med Chem. 2025. PMID: 39851114

10

Identification of serum tRNA-derived small RNAs biosignature for diagnosis of tuberculosis.

Huang Z, Luo Q, Xiong C, Zhu H, Yu C, Xu J, Peng Y, Li J, Le A. Huang Z, et al. Among authors: luo q. Emerg Microbes Infect. 2025 Jan 24:2459132. doi: 10.1080/22221751.2025.2459132. Online ahead of print. Emerg Microbes Infect. 2025. PMID: 39851057

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

7,382 results

Search Page

Filters